C
Chiral Quest
Chiral Quest (Suzhou) Co.,Ltd.__Chiral Quest、Chiral Quest (Suzhou) Co.,Ltd.
About Chiral Quest
Chiral Quest is a specialized company operating in the pharmaceutical sector, focusing on the development and application of asymmetric hydrogenation catalysts. These catalysts are crucial for the synthesis of chiral compounds, which are essential components in many pharmaceutical products. The company serves a wide range of clients within the pharmaceutical industry, including major pharmaceutical companies and research institutions. Chiral Quest operates in a highly specialized market, providing unique solutions that enhance the efficiency and effectiveness of drug development processes. The business model revolves around the development, production, and sale of proprietary catalysts, as well as offering consulting services in process chemistry. Revenue is generated through the sale of these catalysts and consulting fees. The company has a strong presence in global pharmaceutical events and maintains high standards, as evidenced by its successful USFDA audits.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Oct 2022 | $0 | — | CDH Investments · Raymond AMC · Addor Capital | — |
| SERIES COther financing | Aug 2013 | $23M | $92M | Infinity Group · China Singapore Suzhou Industrial Park Ventures · Kaiwu Capital | ↗ |
Growth signals
Latest recorded traffic for Chiral Quest is 890 monthly website visits, up 345% over the last three months. Chiral Quest's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Kleiner Perkins
Japan Asia Investment
Series B and later8 investors entered at this stage
Infinity Group- SDSuzhou Industrial Park Biotech Development
- CIChina Renaissance Capital Investment
- KCKaiwu Capital
China Singapore Suzhou Industrial Park Ventures
CDH Investments- RARaymond AMC
Addor Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chiral Quest on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chiral Quest’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







